Narayana Hrudayalaya Ltd

The Sensex climbed 1.13% on 6 May 2026, yet Narayana Hrudayalaya Ltd outperformed with a 5.4% gain, touching an intraday high of Rs 1852.5. This 3.82 percentage-point outperformance over its Hospital sector peers highlights a stock-specific strength rather than a broad market lift.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Narayana Hrudayalaya Ltd, a mid-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. Despite a modest day gain of 1.12%, the stock’s technical indicators reveal a cautious outlook, prompting a downgrade in its Mojo Grade from Hold to Sell as of 19 Feb 2026.

Narayana Hrudayalaya Ltd, a prominent player in the hospital sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid rising price multiples and intensifying competition within the healthcare industry. Investors are now reassessing the stock’s price attractiveness in light of its elevated price-to-earnings and price-to-book ratios relative to historical averages and peer benchmarks.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Narayana Hrudayalaya Ltd experienced a notable intraday decline on 27 Mar 2026, touching a low of Rs 1,616, reflecting a 5.25% drop from its previous close. The stock underperformed its sector and broader market indices, weighed down by persistent selling pressure and a bearish market environment.

Narayana Hrudayalaya Ltd, a prominent player in the hospital sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid robust operational metrics and a competitive industry landscape. Investors are now reassessing the stock’s price attractiveness in light of its elevated price-to-earnings and price-to-book ratios compared to historical averages and peer benchmarks.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Narayana Hrudayalaya Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite recent share price declines and sector headwinds. This revaluation, driven by improved price-to-earnings and price-to-book ratios relative to peers and historical averages, presents a compelling case for investors seeking mid-cap exposure in the hospital sector.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 14 March 2026, providing investors with an up-to-date view of the company's performance and outlook.

Narayana Hrudayalaya Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a modest decline in price, the stock’s longer-term performance remains robust, though recent signals suggest caution for investors navigating the hospital sector.

Narayana Hrudayalaya Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest decline in the stock price, the company’s long-term returns continue to outperform the broader market, though recent technical signals suggest caution for investors.

Narayana Hrudayalaya Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Narayana Hrudayalaya Ltd, a prominent player in the hospital sector, has seen its investment rating downgraded from Hold to Sell as of 19 Feb 2026. This shift reflects deteriorating financial trends, weakening technical indicators, and a reassessment of valuation metrics, despite the company’s strong long-term fundamentals and market-beating returns over the past decade.